aspirin has been researched along with Infections, Prosthesis-Related in 14 studies
Aspirin: The prototypical analgesic used in the treatment of mild to moderate pain. It has anti-inflammatory and antipyretic properties and acts as an inhibitor of cyclooxygenase which results in the inhibition of the biosynthesis of prostaglandins. Aspirin also inhibits platelet aggregation and is used in the prevention of arterial and venous thrombosis. (From Martindale, The Extra Pharmacopoeia, 30th ed, p5)
acetylsalicylate : A benzoate that is the conjugate base of acetylsalicylic acid, arising from deprotonation of the carboxy group.
acetylsalicylic acid : A member of the class of benzoic acids that is salicylic acid in which the hydrogen that is attached to the phenolic hydroxy group has been replaced by an acetoxy group. A non-steroidal anti-inflammatory drug with cyclooxygenase inhibitor activity.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Aspirin as a venous thromboembolism (VTE) prophylactic agent has been shown to have antistaphylococcal and antibiofilm roles." | 8.12 | Low-Dose Aspirin for Venous Thromboembolism Prophylaxis is Associated With Lower Rates of Periprosthetic Joint Infection After Total Joint Arthroplasty. ( Bernthal, NM; Ciesielka, KA; Kendal, JK; Najafi, F; Parvizi, J; Peterson, NV; Restrepo, C, 2022) |
| "The efficacy and safety of aspirin (ASA) for prevention of venous thromboembolism (VTE) following total joint arthroplasty (TJA) have been demonstrated." | 7.81 | Administration of Aspirin as a Prophylaxis Agent Against Venous Thromboembolism Results in Lower Incidence of Periprosthetic Joint Infection. ( Buckley, PS; Huang, R; Parvizi, J; Purtill, JJ; Scott, B, 2015) |
| "Aspirin as a venous thromboembolism (VTE) prophylactic agent has been shown to have antistaphylococcal and antibiofilm roles." | 4.12 | Low-Dose Aspirin for Venous Thromboembolism Prophylaxis is Associated With Lower Rates of Periprosthetic Joint Infection After Total Joint Arthroplasty. ( Bernthal, NM; Ciesielka, KA; Kendal, JK; Najafi, F; Parvizi, J; Peterson, NV; Restrepo, C, 2022) |
| "Aspirin prophylaxis demonstrated a lower rate of deep vein thrombosis, pulmonary embolism, and venous thromboembolism than warfarin and low-molecular-weight heparin alone throughout all risk scores." | 3.91 | Potent Anticoagulation Does Not Reduce Venous Thromboembolism in High-Risk Patients. ( Chen, AF; Foltz, C; Hansen, EN; Higuera, C; Huang, R; Parvizi, J; Sing, DC; Siqueira, M; Tan, TL, 2019) |
| "The efficacy and safety of aspirin (ASA) for prevention of venous thromboembolism (VTE) following total joint arthroplasty (TJA) have been demonstrated." | 3.81 | Administration of Aspirin as a Prophylaxis Agent Against Venous Thromboembolism Results in Lower Incidence of Periprosthetic Joint Infection. ( Buckley, PS; Huang, R; Parvizi, J; Purtill, JJ; Scott, B, 2015) |
| "Aspirin has been shown to be effective at reducing rates of VTE." | 3.01 | Aspirin Thromboprophylaxis Following Primary Total Knee Arthroplasty Is Associated With a Lower Rate of Early Prosthetic Joint Infection Compared With Other Agents. ( Aggarwal, VK; Anil, U; Kirschner, N; Long, WJ; Lygrisse, KA; Schwarzkopf, R; Sicat, CS; Teo, GM, 2023) |
| "Aspirin was injected intraperitoneally twice daily for 11 days." | 1.51 | Aspirin alleviates orthopedic implant‑associated infection. ( Jiang, Y; Lin, JC; Qin, HJ; Ren, ML; Wang, SN; Wu, HT; Yu, B, 2019) |
| "As aspirin has both anti-inflammatory properties and interferes with platelet aggregation, we hypothesized that ongoing anti-platelet therapy with aspirin may impact clinical and echocardiographic manifestations of CIED infection." | 1.39 | Impact of prior aspirin therapy on clinical manifestations of cardiovascular implantable electronic device infections. ( Anavekar, NS; Baddour, LM; Friedman, PA; Habib, A; Hayes, DL; Irfan, M; Le, KY; Lohse, CM; Sohail, MR; Steckelberg, JM; Wilson, WR, 2013) |
| "Diagnoses included dilated cardiomyopathy (n = 15), myocarditis (n = 2), and postcardiotomy ventricular failure (n = 1)." | 1.33 | Ventricular assist device support in children and adolescents as a bridge to heart transplantation. ( Buchanan, JR; Gandhi, SK; Kormos, RL; Morell, VO; Sharma, MS; Wearden, PD; Webber, SA, 2006) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (7.14) | 18.2507 |
| 2000's | 3 (21.43) | 29.6817 |
| 2010's | 6 (42.86) | 24.3611 |
| 2020's | 4 (28.57) | 2.80 |
| Authors | Studies |
|---|---|
| Najafi, F | 1 |
| Kendal, JK | 1 |
| Peterson, NV | 1 |
| Ciesielka, KA | 1 |
| Restrepo, C | 1 |
| Parvizi, J | 3 |
| Bernthal, NM | 1 |
| Anil, U | 1 |
| Kirschner, N | 1 |
| Teo, GM | 1 |
| Lygrisse, KA | 1 |
| Sicat, CS | 1 |
| Schwarzkopf, R | 1 |
| Aggarwal, VK | 1 |
| Long, WJ | 1 |
| Jiang, Y | 1 |
| Wang, SN | 1 |
| Wu, HT | 1 |
| Qin, HJ | 1 |
| Ren, ML | 1 |
| Lin, JC | 1 |
| Yu, B | 1 |
| Eisen, DP | 1 |
| McEwen, P | 1 |
| Hansen, R | 1 |
| Pandey, S | 1 |
| Wallis, SC | 1 |
| Roberts, JA | 1 |
| Wei, YP | 1 |
| Chien, JC | 1 |
| Hsiang, WH | 1 |
| Yang, SW | 1 |
| Chen, CY | 1 |
| Tan, TL | 1 |
| Foltz, C | 1 |
| Huang, R | 2 |
| Chen, AF | 1 |
| Higuera, C | 1 |
| Siqueira, M | 1 |
| Hansen, EN | 1 |
| Sing, DC | 1 |
| Buckley, PS | 1 |
| Scott, B | 1 |
| Purtill, JJ | 1 |
| Mekni, MA | 1 |
| Achour, W | 1 |
| Ben Hassen, A | 1 |
| Habib, A | 1 |
| Irfan, M | 1 |
| Baddour, LM | 1 |
| Le, KY | 1 |
| Anavekar, NS | 1 |
| Lohse, CM | 1 |
| Friedman, PA | 1 |
| Hayes, DL | 1 |
| Wilson, WR | 1 |
| Steckelberg, JM | 1 |
| Sohail, MR | 1 |
| Gallego, P | 1 |
| Marin, F | 1 |
| Lip, GY | 2 |
| Kowalik, Z | 1 |
| Kucharski, A | 1 |
| Hobot, J | 1 |
| Sharma, MS | 1 |
| Webber, SA | 1 |
| Morell, VO | 1 |
| Gandhi, SK | 1 |
| Wearden, PD | 1 |
| Buchanan, JR | 1 |
| Kormos, RL | 1 |
| Demirag, MK | 1 |
| Esen, S | 1 |
| Zivalioglu, M | 1 |
| Leblebicioglu, H | 1 |
| Keceligil, HT | 1 |
| Goldsmith, I | 1 |
| Mukundan, S | 1 |
| Rosin, MD | 1 |
1 review available for aspirin and Infections, Prosthesis-Related
| Article | Year |
|---|---|
Aspirin Thromboprophylaxis Following Primary Total Knee Arthroplasty Is Associated With a Lower Rate of Early Prosthetic Joint Infection Compared With Other Agents.
Topics: Anticoagulants; Arthritis, Infectious; Arthroplasty, Replacement, Hip; Arthroplasty, Replacement, Kn | 2023 |
13 other studies available for aspirin and Infections, Prosthesis-Related
| Article | Year |
|---|---|
Low-Dose Aspirin for Venous Thromboembolism Prophylaxis is Associated With Lower Rates of Periprosthetic Joint Infection After Total Joint Arthroplasty.
Topics: Anticoagulants; Arthritis, Infectious; Arthroplasty, Replacement, Hip; Arthroplasty, Replacement, Kn | 2022 |
Aspirin alleviates orthopedic implant‑associated infection.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Disease Models, Animal; Female; Humans; I | 2019 |
Low levels of salicylic acid and salicyluric acid are present in synovial fluid of patients taking aspirin at the time of knee arthroplasty surgery.
Topics: Administration, Oral; Adolescent; Anti-Inflammatory Agents, Non-Steroidal; Arthroplasty, Replacement | 2020 |
Aspirin administration might accelerate the subsidence of periprosthetic joint infection.
Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Aspirin; Case-Control Studies; Drug Therapy, | 2020 |
Potent Anticoagulation Does Not Reduce Venous Thromboembolism in High-Risk Patients.
Topics: Aged; Anticoagulants; Arthroplasty, Replacement; Aspirin; Female; Heparin, Low-Molecular-Weight; Hum | 2019 |
Administration of Aspirin as a Prophylaxis Agent Against Venous Thromboembolism Results in Lower Incidence of Periprosthetic Joint Infection.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Inflammatory Agents, Non-Steroidal; Anticoagulants; | 2015 |
Comment on the effect of aspirin on adherence of slime-producing, coagulase-negative Staphylococci to vascular grafts.
Topics: Aspirin; Bacterial Adhesion; Blood Vessel Prosthesis; Humans; Prosthesis-Related Infections; Staphyl | 2012 |
Impact of prior aspirin therapy on clinical manifestations of cardiovascular implantable electronic device infections.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Aspirin; Defibrillators, Implantable; Echocardiography; | 2013 |
Prior aspirin therapy and cardiovascular implantable electronic device infections.
Topics: Aspirin; Defibrillators, Implantable; Endocarditis; Female; Humans; Male; Prosthesis-Related Infecti | 2013 |
Use of dacron vascular prosthesis impregnated with salts of silver, in treatment of extraanatomical axilla-femoral by-pass's infection. Infections in vascular surgery.
Topics: Aged; Aneurysm, Infected; Anti-Bacterial Agents; Aspirin; Blood Vessel Prosthesis; Coated Materials, | 2002 |
Ventricular assist device support in children and adolescents as a bridge to heart transplantation.
Topics: Adolescent; Anticoagulants; Aprotinin; Aspirin; Cardiomyopathy, Dilated; Child; Child, Preschool; Da | 2006 |
The effect of aspirin on adherence of slime-producing, coagulase-negative staphylococci to vascular grafts.
Topics: Aspirin; Bacterial Adhesion; Blood Vessel Prosthesis; Coagulase; Colony Count, Microbial; Humans; Po | 2007 |
Experience with low-dose aspirin as thromboprophylaxis for the Tissuemed porcine aortic bioprosthesis: a survey of five years' experience.
Topics: Aged; Aged, 80 and over; Aortic Valve; Aspirin; Bioprosthesis; Data Collection; Dose-Response Relati | 1998 |